Cargando…

Data Speak How to Treat Disease: Big data-based precision medicine

Detalles Bibliográficos
Autor principal:	Hwang, Daehee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Molecular and Cellular Biology 2022
Materias:	Journal Club
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448643/ https://www.ncbi.nlm.nih.gov/pubmed/36058889 http://dx.doi.org/10.14348/molcells.2022.0119

Ejemplares similares

Nanotubes Make Big Science
por: Demontis, Fabio
Publicado: (2004)

Deep Learning Approach Based on Transcriptome Profile for Data Driven Drug Discovery
por: Kwon, Eun-Ji, et al.
Publicado: (2023)

Repurposing drugs to treat neurological diseases
por: Massey, T. H., et al.
Publicado: (2018)

How to test Molyneux's question empirically
por: Connolly, Kevin
Publicado: (2013)

How the Human Brain Segments Continuous Experience
por: Williams, Angharad N., et al.
Publicado: (2019)

How Does Global Warming Sabotage Plant Immunity?
por: Dhar, Souvik, et al.
Publicado: (2022)

Reversing the trend: interventions to treat intracranial haemorrhage associated with anticoagulation
por: McLauchlan, D., et al.
Publicado: (2016)

Modelling how initiating and transforming oncogenes cooperate to produce a leukaemic cell state
por: Richardson, Simon E.
Publicado: (2013)

How Can We Predict the Successful Outcome After Treatment in Achalasia Patients? (Gastroenterology 2012;143:328-335)
por: Hong, Su Jin
Publicado: (2012)

Disease-modifying treatments in Alzheimer’s disease
por: Edwards, Marc, et al.
Publicado: (2023)

“Knowing” Can Be the Medicine for Expecting Mothers: RNA signatures from a single blood sampling during pregnancy can detect a pathologic condition before its onset.
por: Lee, Sun-Kyung
Publicado: (2022)

Where Does N-Formylmethionine Come from? What for? Where Is It Going?: What is the origin of N-formylmethionine in eukaryotic cells?
por: Lee, Chang-Seok, et al.
Publicado: (2022)

Genetics of disease severity in multiple sclerosis, Alzheimer’s disease, and Huntington’s disease: rejuvenating genome-wide association studies
por: Hrastelj, James, et al.
Publicado: (2017)

Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
por: Willis, M. D., et al.
Publicado: (2018)

Treatments in Alzheimer’s disease
por: Malik, G. A., et al.
Publicado: (2017)

Pathological looping in the synucleinopathies: investigating the link between Parkinson’s disease and Gaucher disease
por: Kinghorn, Kerri J.
Publicado: (2011)

Sleep disorders in Parkinson’s disease
por: Hawken, Jonathan, et al.
Publicado: (2022)

New treatments in Alzheimer’s disease
por: Pickrell, William O., et al.
Publicado: (2018)

The gut microbiome: neurological development and disease
por: Miah, Latif, et al.
Publicado: (2022)

The economic burden of chronic neurological disease
por: Wynford-Thomas, R., et al.
Publicado: (2017)

Seizures in Alzheimer’s disease: is there more beneath the surface?
por: Edwards, Marc, et al.
Publicado: (2017)

New ways of looking at an old disease: the reimagination of epilepsy
por: Mitchell, Clinton J., et al.
Publicado: (2016)

Stem cells in the treatment of central nervous system disease
por: McLauchlan, Duncan, et al.
Publicado: (2018)

Creutzfeldt–Jacob disease: new directions in diagnosis and therapeutics
por: Al-Ansari, Aseel, et al.
Publicado: (2017)

Systems-based thinking in psychology and the mental health sciences
por: Ebrahimi, Omid V.
Publicado: (2023)

A NOD to zebrafish models of inflammatory bowel disease pathogenesis
por: Allen, Irving C.
Publicado: (2011)

Multiple sclerosis: early indicators of disease and assessing future risk
por: Willis, M. D., et al.
Publicado: (2020)

Understanding gene-environment interactions in a mouse model of Crohn’s disease
por: Duckworth, Carrie A.
Publicado: (2011)

Parkin’ control: regulation of PGC-1α through PARIS in Parkinson’s disease
por: Castillo-Quan, Jorge Iván
Publicado: (2011)

Maple syrup urine disease: new insights from a zebrafish model
por: Roberts, Nathan B.
Publicado: (2012)

Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
por: McArthur, C., et al.
Publicado: (2023)

The role of skin biopsy in differentiating idiopathic Parkinson’s disease from other types of parkinsonism
por: Wynford-Thomas, Ray, et al.
Publicado: (2015)

Journal Club: Efficacy of Tocilizumab in Early Systemic Sclerosis–Related Interstitial Lung Disease
por: Tiwari, Vivekanand, et al.
Publicado: (2021)

The exposome in respiratory diseases: multiple preventable risk factors from early life to adulthood
por: Savouré, Marine, et al.
Publicado: (2023)

Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies
por: Allman, M., et al.
Publicado: (2022)

Does 22q11.2 deletion syndrome contribute to the genetic aetiology of Parkinson’s disease?
por: Fung, W., et al.
Publicado: (2018)

What Is the Profiles for Predicting Treatment Responsiveness in Gastroesophageal Reflux Disease? (Gut 2012;61:501-506)
por: Park, Seon Young
Publicado: (2012)

Anteil an Geimpften in der Bevölkerung und Coronavirus Disease 2019(COVID‑19)-Fälle – Limitationen und irreführende Schlussfolgerungen
por: Umlauf, Julian, et al.
Publicado: (2022)

Cellular Senescence: The Villain of Metabolic Disease?: Discovery of a distinct senescent cell population in obesity-induced metabolic dysfunction
por: Lee, Gung
Publicado: (2022)

Idiopathic rapid eye movement sleep behaviour disorder: a potential gateway to the development of disease-modifying treatments in neurodegenerative disorders
por: Peall, K. J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gdsi913l75ntrrnn172312mht7